Stock 4599 STEMRIM
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases StemRIM

Equities

4599

JP3399690001

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-06-05 am EDT 		5-day change 1st Jan Change
470 JPY 0.00% Intraday chart for StemRIM +4.44% -18.69%
May. 09 StemRIM to Seek Shareholders' Approval on Capital Stock Reduction MT
Mar. 13 StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shionogi & Co., Ltd. - Orphan Drug Designation for Redasemtide for Dystrophic Epidermolysis Bullosa
AQ
SHIONOGI Announces Positive Results from a Phase 2 Clinical Trial of the Regeneration Inducing Medicine S-005151 in Patients with Acute Ischemic Stroke
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4599 Stock
  4. News StemRIM
  5. Press Releases